China National Medicines Corporation Ltd.
600511
Rang in aandelen
#4874
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aandeelprijs
$4.00
Marktkapitalisatie
$3.02B
Verandering (1 dag)
2.49%
Verandering (1 jaar)
-1.19%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)
Categorie
Healthcare
Omzet van China National Medicines Corporation Ltd. (600511)
Omzet in Jun 2026 TTM: $7.76B
Volgens de laatste financiële rapporten van China National Medicines Corporation Ltd. bedraagt de huidige omzet van het bedrijf (TTM) $7.76B. In 2023 behaalde het bedrijf een omzet van $7.02B een stijging ten opzichte van de omzet in het jaar 2022, die $6.60B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van China National Medicines Corporation Ltd. van 2000 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $7.76B | 11.97% |
| 2024 | $6.93B | -1.26% |
| 2023 | $7.02B | 6.44% |
| 2022 | $6.60B | -9.78% |
| 2021 | $7.31B | 18.28% |
| 2020 | $6.18B | -3.59% |
| 2019 | $6.41B | 13.84% |
| 2018 | $5.63B | 0.99% |
| 2017 | $5.58B | 11.87% |
| 2016 | $4.99B | 168.02% |
| 2015 | $1.86B | -0.15% |
| 2014 | $1.86B | 12.08% |
| 2013 | $1.66B | 20.63% |
| 2012 | $1.38B | 23.34% |
| 2011 | $1.12B | 24.59% |
| 2010 | $896.61M | 17.84% |
| 2009 | $760.87M | 18.39% |
| 2008 | $642.69M | 31.31% |
| 2007 | $489.45M | 36.11% |
| 2006 | $359.59M | 24.36% |
| 2005 | $289.14M | 32.86% |
| 2004 | $217.63M | 22.35% |
| 2003 | $177.87M | 20.30% |
| 2002 | $147.86M | 0.22% |
| 2001 | $147.54M | 11.05% |
| 2000 | $132.86M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $410.98B | 5,194.83% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,175.56% |
US
|
|
| - | - |
US
|
|
| $7.64B | -1.55% |
AU
|
